ArticleAfrican health sciences2022

Evaluation of treatment efficacy after switching to dolutegravir-lamivudine dual therapy in people living with HIV.

Pınar Ergen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.